Click Here to return To Results

 

Sustained-Release Oral Fampridine in Multiple Sclerosis: A Randomised, Double-Blind, Controlled Trial Lancet 373:732-738, Goodman,A.D.,et al, 2009 See this aricle in Pubmed Article Abstract Fampridine improved walking ability in some people with multiple sclerosis. This improvement was associated with a reduction of patients� reported ambulatory disability, and is a clinically meaningful therapeutic benefit.

Related Tags

(click to filter results - removes previous filter) aminopyridine,4 efficacy multiple sclerosis multiple sclerosis,treatment of safety treatment of neurologic disorder

Click Here to return To Results